한국어
English
日本語
中文(简体)
Epalle (Epalerastat)
50mg
Tablet · Prescription medication
Jungheon Pharmaceutical Co., Ltd.
Epalrestat is a drug used for the improvement of diabetic neuropathy.
MFDS ingredient code M050620
Epalrestat belongs to the class of aldose reductase inhibitors. It is primarily used to alleviate nerve damage that occurs in diabetic patients.
Epalrestat inhibits the activity of aldose reductase, preventing excessive conversion of glucose to sorbitol. This reduces the accumulation of toxic substances in nerve cells, preventing nerve damage and improving symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Epalrestat has superior neuroprotective effects compared to other aldose reductase inhibitors and tends to have relatively fewer side effects. Additionally, it is available for oral administration, increasing patient convenience.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.